Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Transplantation Proceedings|July 8, 2014
Liver transplantation in a patient with clinical manifestations of cryptogenic cirrhosis: a case report of hepar lobatum as a primary liver conditionJ F L Bonfitto, T J A P Mattosinho, I Neves, et al.Plos One|July 26, 2012
Circulating tumor cells in melanoma patientsGary A Clawson, Eric Kimchi, Susan D Patrick, et al.Cancer Biology & Therapy|December 2, 2016
Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab aloneKristian M Koller, Heath B Mackley, Jason Liu, et al.BMC Health Services Research|April 24, 2020
No man is an island: spatial clustering and access to primary care as possible targets for the development of new community mental health approachesM Nascimento, B Lourenço, I Coelho, et al.Plastic and Reconstructive Surgery|June 1, 2005
Sentinel lymph node biopsy in cutaneous melanoma: analysis of 240 consecutive casesJoão P Duprat, Débora C P Silva, Felipe J F Coimbra, et al.Critical Reviews in Oncology/Hematology|September 18, 2016
Malignant melanoma-The cradle of anti-neoplastic immunotherapyKristian M Koller, Wenge Wang, Todd D Schell, et al.The Oncologist|August 12, 2016
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell CarcinomaMario E Lacouture, Brigitte Dréno, Paolo Antonio Ascierto, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 26, 1998
Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. Evandro Chagas Hospital AIDS Clinical Research GroupM G Morgado, M L Guimarães, C B Gripp, et al.ACS Pharmacology & Translational Science|November 14, 2024
Tumor Heterogeneity Shapes Survival Dynamics in Drug-Treated Cells, Revealing Size-Drifting SubpopulationsVenugopal Vangala, Yu-Chi Chen, Saketh S Dinavahi, et al.Journal for Immunotherapy of Cancer|January 14, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trialAndrew S Brohl, Vernon K Sondak, Evan J Wuthrick, et al.Pageof 8